光漂白
高含量筛选
活体细胞成像
单细胞分析
表型筛选
药物发现
显微镜
荧光寿命成像显微镜
显微术
生物系统
表型
细胞
生物物理学
纳米技术
计算机科学
生物
材料科学
细胞生物学
生物信息学
荧光
病理
光学
医学
物理
生物化学
基因
遗传学
作者
Erin L. Dunnington,Kit Chiu,Brian Wong,Anthony Chales-Antonio,Victoria Y. T. Pang,WU Yu-ling,Dan Fu
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2025-08-04
标识
DOI:10.1101/2025.08.02.668298
摘要
ABSTRACT Image-based phenotypic screening has emerged as a powerful tool for revealing single-cell heterogeneity and dynamic phenotypic responses in preclinical drug discovery. Compared to traditional static end-point assays, live-cell longitudinal imaging captures the temporal trajectories of individual cells, including transient morphological adaptations, motility shifts, and divergent subpopulation behaviors, enabling high content features and more robust early prediction of treatment outcomes. Fluorescence-based screening, while highly specific, is constrained in live-cell contexts by broad spectral overlaps (limiting multiplexing to fewer than six channels), bulky fluorophores that may perturb small-molecule interactions, and photobleaching or phototoxicity under repeated excitation. Stimulated Raman scattering (SRS) microscopy overcomes these barriers by delivering label-free, quantitative chemical contrasts alongside morphological information. Here, we present a low-cost, 3D printed cell culture platform compatible with the stringent optical requirements of SRS microscopy. This set up enables real-time drug delivery and continuous monitoring of biochemical and morphological changes in living cells during 24-hour time-lapse imaging with minimal photodamage. We outline a processing pipeline for longitudinal SRS images to extract chemical and morphological features of single live cells. Using this system, we showcase time-lapse SRS microscopy as a tool to map heterogenous drug-induced single-cell response over time, enabling the identification of varying trajectories within complex cell populations. By parallelizing multi-well perfusion with label-free chemical imaging, our approach offers a pathway toward high-throughput pharmacodynamic assays for the acceleration of phenotypic screening and personalized medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI